ABLSX
Price
$13.30
Change
+$0.05 (+0.38%)
Updated
Jan 17 closing price
Net Assets
109.31M
CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
238.66B
Ad is loading...

ABLSX vs CLBCX

Header iconABLSX vs CLBCX Comparison
Open Charts ABLSX vs CLBCXBanner chart's image
American Beacon Balanced Adv
Price$13.30
Change+$0.05 (+0.38%)
VolumeN/A
Net Assets109.31M
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets238.66B
ABLSX vs CLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABLSX vs. CLBCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABLSX is a Hold and CLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 239B vs. ABLSX (109M). CLBCX (1.52) and ABLSX (1.47) have matching dividends . ABLSX was incepted earlier than CLBCX: ABLSX (20 years) vs CLBCX (23 years). CLBCX is a more actively managed with annual turnover of: 171.00 vs. ABLSX (48.00). CLBCX has a lower initial minimum investment than ABLSX: CLBCX (250) vs ABLSX (2500). CLBCX annual gain was more profitable for investors over the last year : 11.42 vs. ABLSX (5.22). CLBCX return over 5 years is better than : 26.62 vs. ABLSX (-4.23).
ABLSXCLBCXABLSX / CLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD1.9941.894105%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets109M239B0%
Annual Yield % from dividends1.471.5296%
Returns for 1 year5.2211.4246%
Returns for 3 years-5.4611.24-49%
Returns for 5 years-4.2326.62-16%
Returns for 10 years-3.7056.78-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin